文献速递皮肤肿瘤

蓝痣数字随访皮肤镜变化分析:一项21年回顾性队列研究

Analysis of dermoscopic changes of blue nevi on digital follow-up: A 21-year retrospective cohort study.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2023-03-27

该研究回顾性分析了1998年12月至2019年11月间103例患者的123枚蓝痣,利用人工智能算法和分割神经网络评估皮损面积变化。99枚(91.7%)蓝痣稳定,9枚(8.3%)生长,其中2枚(1.85%)显著生长;生长的蓝痣为细胞性蓝痣,低肿瘤突变负荷,两枚均检出GNAQ c.626A>T改变。作者结论为大多数蓝痣保持稳定,罕见可进展性生长但未发现恶性组织病理或分子征象。

要点

  • 大多数蓝痣(91.7%)在数字随访中保持稳定。
  • 8.3%的蓝痣出现生长,其中1.85%显著生长。
  • 生长的蓝痣为细胞性蓝痣,伴GNAQ c.626A>T改变,未见恶性征象。

核心结论

  • 大多数蓝痣在演变过程中保持稳定,罕见情况下可显示进展性生长,但未发现恶性组织病理或分子征象。

研究设计与样本

  • 回顾性队列研究,纳入1998年12月至2019年11月间随访的103例患者,共123枚蓝痣,使用人工智能算法从两个数字表皮发光设备数据库中识别蓝痣,并通过分割神经网络计算每枚皮损面积变化。

主要发现

  • 在分割的皮损中,99枚(91.7%)蓝痣被认为稳定。
  • 在识别的9枚(8.3%)生长蓝痣中,2枚(1.85%)显示显著生长。
  • 所研究的生长蓝痣为细胞性蓝痣,呈现低肿瘤突变负荷,且两枚病灶均检出GNAQ c.626A>T改变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 一些蓝痣的临床变异型可能未被纳入。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Blue nevi are benign dermal melanocytic proliferations that are often easy to recognize clinically. Rarely, these lesions can display atypical features, suggesting the presence of a malignant blue nevus or mimicking cutaneous metastases of melanoma. OBJECTIVE: To describe the clinical evolution of blue nevi over time and to assess the need for monitoring these lesions. METHODS: We conducted a retrospective cohort study of 103 patients who were followed between December 1998 and November 2019. An artificial intelligence algorithm was used to identify blue nevi from the databases of two digital epiluminescence devices. Changes in the area of each lesion were calculated with a segmentation neural network. RESULTS: We included 123 blue nevi from 103 patients. Most of the lesions segmented, 99 (91.7%), were considered stable. Of the 9 (8.3%) growing blue nevi identified, 2 (1.85%) showed significant growth. The studied growing blue nevi turned out to be cellular blue nevi, presented with a low tumour mutation burden and GNAQ c.626A>T alteration was identified in both lesions. LIMITATIONS: Some clinical variants of blue nevi might not be included. CONCLUSIONS: Most blue nevi remain stable during their evolution. Rarely, they can show progressive growth, although histopathological or molecular signs of malignancy have not been identified.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Alamon-Reig F, Combalia M, Albero-González R, et al. Analysis of dermoscopic changes of blue nevi on digital follow-up: A 21-year retrospective cohort study. J Eur Acad Dermatol Venereol. 2023. PMID: 36695073. doi:10.1111/jdv.18915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。